UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $756M
- YoY, 2025
- +6.5%
- 10-year CAGR
- +5.3%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $756M | +6.5% |
| 2024 | $710M | +48.8% |
| 2023 | $477M | −1.0% |
| 2022 | $482M | +3.2% |
| 2021 | $467M | — |
| 2018 | $266M | −19.5% |
| 2017 | $330M | +4.2% |
| 2016 | $317M | −30.0% |
| 2015 | $453M | +18.7% |
| 2014 | $381M | −3.2% |
| 2013 | $394M | +95.3% |
| 2012 | $202M | +28.9% |
| 2011 | $156M | −17.0% |
| 2010 | $189M | +9.7% |
| 2009 | $172M | +82.3% |
| 2008 | $94M | — |